Author:
Verdini Federico,Abramova Anna,Boffa Luisa,Calcio Gaudino Emanuela,Cravotto Giancarlo
Abstract
AbstractThe degradation in water of furosemide (FUR), a widely used diuretic drug, was herein reported. The method entails an integrated approach based on the hybridisation of hydrodynamic cavitation (HC) with electrical discharge (ED) plasma technology. This dynamic duo could increase the production of oxidising compounds in water, in particular hydroxyl radicals (OH radicals), by triggering the rapid homolytic decomposition of water molecules and avoiding the addition of external oxidants. This study clearly emphasises the effectiveness of an integrated approach to improve the degradation of pollutants in wastewater originating from active pharmaceutical ingredients (APIs). The results of HC/ED-assisted FUR degradation in the presence of radical scavengers highlight the predominant role of the radical oxidation mechanism at the gas–liquid interface of the cavitation bubble during HC/ED treatment. A comparative analysis of the three technologies—HC alone, HC/ED and UV alone—emphasised the promising potential of hybrid HC/ED as a scalable industrial technology. This is demonstrated by the higher degradation rates (100%, 10 min) when treating large volumes (5L) of wastewater contaminated with FUR (50 mg/L), even in the presence of other APIs.
Publisher
Springer Science and Business Media LLC
Reference49 articles.
1. Eniola, J. O., Kumar, R., Barakat, M. A. & Rashid, J. A review on conventional and advanced hybrid technologies for pharmaceutical wastewater treatment. J. Clean. Prod. 356, 131826 (2022).
2. https://www.epa.gov/waterreuse/basic-information-about-water-reuse
3. Hernández-Tenorio, R., González-Juárez, E., Guzmán-Mar, J. L., Hinojosa-Reyes, L. & Hernández-Ramírez, A. Review of occurrence of pharmaceuticals worldwide for estimating concentration ranges in aquatic environments at the end of the last decade. J. Hazard. Mater. Adv. 8, 100172 (2022).
4. Prandota, J. Clinical pharmacology of furosemide in children: a supplement. Am. J. Ther. 8(4), 275–289 (2001).
5. https://www.verifiedmarketreports.com/product/lasix-market